CMR phenotypes and clinical outcomes in NYHA class I versus II-IV hypertrophic cardiomyopathy: identifying high-risk asymptomatic patients
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
Libin Cardiovascular Institute Of Alberta, Calgary (Canada)
6 More presentations in this session
Doctor H. Lee (Seoul, KR)
Doctor M. Golino (Jacksonville, US)
Doctor E. Hancioglu (Hatay, TR)
Doctor M. Marques Antunes (Lisboa, PT)
Doctor K. Fragkiadakis (Heraklion, GR)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
